Denali Capital Acquisition Corp. extends business combination deadline to July 11, 2025

Semnur Pharmaceuticals, Inc.

Deposited $874.78 into trust account to extend deadline from June 11 to July 11, 2025.
Extension funded via convertible promissory note from Scilex Holding (SCLX) with principal up to $180,000.
Note bears no interest, convertible at $10.00/share upon business combination; remaining $56,920.74 available for future extensions.
Note repayable on earlier of business combination or liquidation of the company.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.